Several nonoverlapping epitopes were mapped on the primary sequence of the Sendai virus NP protein. After a complete cDNA clone of the Sendai virus NP gene was expressed in Escherichia coli, deletion constructs were used to generate a series of overlapping NP fragments deleted at their C termini. Immunoblot analyses with 11 monoclonal antibodies identified four antigenic sites. All of these sites resided in the C-terminal half of NP and were also the only sites detected with a polyclonal serum. These findings confirm and extend the evidence that the C terminus of the NP protein represents the domain exposed on the surface of the nucleocapsid. One of the monoclonal antibodies reacted with a site, comprising only 6 amino acids, lying with a hinge between an a-helix and a ,B-strand in the predicted secondary structure of NP. Since this antibody is a potent inhibitor of in vitro viral RNA synthesis (K. L. Deshpande and A. Portner, Virology 139:32-42, 1984), the epitope may be critical to the flexibility of the NP molecule that makes the RNA template accessible during RNA synthesis.
Sendai virus, a useful laboratory model of the medically important paramyxovirus family, contains a ribonucleoprotein core (nucleocapsid) enclosed in a membrane derived from the host cell (4) . The nucleocapsid serves as the template for viral RNA synthesis (11) . The major structural component of the nucleocapsid is the NP protein, comprising 517 amino acids (10) .
Previous studies showed that some monoclonal antibodies (MAbs) against NP protein inhibited virus-specific RNA synthesis (6) . To relate the functional effects of these MAbs to the structure of the protein, we have now mapped their epitopes on deletion constructs made in bacteria.
To express NP protein in Escherichia coli, the NP gene was inserted in the expression plasmid pRC23 (5) . Transcription of a heterologous gene inserted in pRC23 is driven by the APL promoter which is under the control of the temperature-sensitive cI repressor encoded by the compatible plasmid pRK248cIts (1) . Therefore, the expression of a heterologous gene is repressed during bacterial growth at 30°C and induced by shifting to 42°C. The strategy used in the construction of plasmids pRC-NP and pGT-NP for Sendai virus NP expression is shown in Fig. 1 . In brief, the NP-coding sequence was placed between the ribosome-binding site of expression vector pRC23 and a synthetic translation terminator sequence. This sequence permitted the precise termination of protein fragments expressed from deletion constructs of pGT-NP.
The expression of NP protein by E. coli in the presence or absence of an active X repressor was detected by immunoblotting with MAbs (Fig. 2, lanes 1 to 4) (Fig. 3A ). Constructs were confirmed by restriction analyses of the plasmid DNAs (2) . Their ability to synthesize NP protein fragments truncated at their C termini was tested by in vitro coupled transcription-translation of isolated plasmid DNAs (Fig. 3B) . The electrophoretic mobility of the largest polypeptide in each lane was in good agreement with its predicted size. Smaller bands were probably products initiated from AUG codons downstream of the first initiating AUG in the NP mRNA. A protein band with an Mr of 34,000 was present in all cases, except the control. This band may represent the product of the Ampr gene encoded in the plasmid DNAs. Similarly, another light band which fortuitously migrated at the same rate as full-length NP protein was present in all samples and is therefore assumed to be a bacterial protein.
Of 16 MAbs tested, 11 reacted with the NP fragments (Fig.  4) . The five MAbs which failed to react in the immunoblots had been selected by reaction with native NP in enzymelinked immunosorbent assays (6) and presumably had noncontinuous epitopes which were destroyed by denaturation before electrophoresis. Two antibodies (M8 and M52) reacted only with full-length NP protein ( Fig. 4A and B) , showing that their epitopes were lost with deletion of the C-terminal 62 amino acids of NP which we have designated region I. Five antibodies (M13, M17, M19, M73, and WS16) reacted only with the second largest peptide and full-length NP ( Fig. 4C and D (Fig. 4E) . Their failure to react with the products of constructs d, e, f, and g (Fig. 3A) placed their epitopes in a region which lies between amino acids 289 and 425 (region III). Antibody M4 was previously shown to recognize a trypsin digestion product (Mr, 34,000) of NP containing the first 295 amino acids from the N terminus (6). Thus, the epitope for M4 resides between amino acids 289 and 295 (region IIIa). This finding was confirmed with immunoblots of a protein product of a deletion construct containing the first 295 amino acids of NP (Fig. 3A, construct  h ), made by using the HindIll site in the NP gene, which coincides with the trypsin cleavage site in the NP protein ( Fig. 4G and H) . A polyclonal serum was obtained from a rabbit which had been immunized and reboosted with an emulsion of a commercial adjuvant (RIBI Immuno Chemical by centrifuging 1 ml of each culture and boiling the culture in sample loading buffer for separation by electrophoresis on a 10% sodium dodecyl sulfate-polyacrylamide gel (9) . Sendai virus proteins disrupted with sodium dodecyl sulfate were run in the indicated lane (VIRUS). Separated proteins were transferred to nitrocellulose (12) , treated with a mixture of anti-NP monoclonal antibodies, and analyzed by peroxidase immunoassay (6).
Research, Inc.) and NP protein electroeluted from a sodium dodecyl sulfate-polyacrylamide gel (9) . Like the MAbs, anti-NP serum failed to detect the protein products of the deletion constructs d, e, f, and g (Fig. 4F) .
A significant finding was the reaction of all of the MAbs with the C-terminal half of the protein. Biochemical studies indicated that the C-terminal 120 amino acids of NP reside on the surface of the virus core (7) . We have now located regions which lie on the surfaces of NP molecules within the viral nucleocapsids at least 100 more amino acids further towards the N terminus. Selection of the MAbs used in this work by enzyme-linked immunosorbent assay of binding to native nucleocapsids from virions may therefore explain the absence of any reactivities with the N-terminal half of the NP protein. It is more difficult to understand why the polyclonal serum failed to react with polypeptides representing this region. However, the isolation of MAbs restricted to limited regions of viral proteins has been reported for the NS protein of vesicular stomatitis virus (14), the P protein of Sendai virus (13), and the a4 protein of herpes simplex virus 1 (8) . Perhaps all of these cases represent regional clustering of strongly antigenic sites, a possibility that may have implications for understanding immune defenses against viral infections.
The epitope for one of the antibodies (M4) was localized to a region of 6 amino acids (residues 290 to 295). An analysis of the predicted NP secondary structure (10) exposed for interaction with the nucleocapsid-associated RNA polymerase during RNA synthesis. This may explain why binding of this particular antibody to NP in nucleocapsids strongly inhibits RNA synthesis in vitro (6) .
